| UniProt ID | CBPA4_HUMAN | |
|---|---|---|
| UniProt AC | Q9UI42 | |
| Protein Name | Carboxypeptidase A4 | |
| Gene Name | CPA4 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 421 | |
| Subcellular Localization | Secreted. | |
| Protein Description | Metalloprotease that could be involved in the histone hyperacetylation pathway. [PubMed: 10383164 Releases a C-terminal amino acid, with preference for -Phe, -Leu, -Ile, -Met, -Tyr and -Val] | |
| Protein Sequence | MRWILFIGALIGSSICGQEKFFGDQVLRINVRNGDEISKLSQLVNSNNLKLNFWKSPSSFNRPVDVLVPSVSLQAFKSFLRSQGLEYAVTIEDLQALLDNEDDEMQHNEGQERSSNNFNYGAYHSLEAIYHEMDNIAADFPDLARRVKIGHSFENRPMYVLKFSTGKGVRRPAVWLNAGIHSREWISQATAIWTARKIVSDYQRDPAITSILEKMDIFLLPVANPDGYVYTQTQNRLWRKTRSRNPGSSCIGADPNRNWNASFAGKGASDNPCSEVYHGPHANSEVEVKSVVDFIQKHGNFKGFIDLHSYSQLLMYPYGYSVKKAPDAEELDKVARLAAKALASVSGTEYQVGPTCTTVYPASGSSIDWAYDNGIKFAFTFELRDTGTYGFLLPANQIIPTAEETWLGLKTIMEHVRDNLY | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 38 | Phosphorylation | VRNGDEISKLSQLVN ECCHHHHHHHHHHHH | 26.04 | - | |
| 78 | Phosphorylation | VSLQAFKSFLRSQGL HHHHHHHHHHHHCCC | 24.06 | 24719451 | |
| 210 | Phosphorylation | QRDPAITSILEKMDI CCCHHHHHHHHHCCE | 21.04 | 24719451 | |
| 260 | N-linked_Glycosylation | ADPNRNWNASFAGKG CCCCCCCCCCCCCCC | 29.29 | 15738388 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CBPA4_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CBPA4_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CBPA4_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| LXN_HUMAN | LXN | physical | 15738388 | |
| NUCG_HUMAN | ENDOG | physical | 26186194 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Structure of human carboxypeptidase A4 with its endogenous proteininhibitor, latexin."; Pallares I., Bonet R., Garcia-Castellanos R., Ventura S., Aviles F.X.,Vendrell J., Gomis-Rueth F.-X.; Proc. Natl. Acad. Sci. U.S.A. 102:3978-3983(2005). Cited for: X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 114-421 IN COMPLEX WITH LXN,GLYCOSYLATION AT ASN-260, AND DISULFIDE BOND. | |
| "Detailed molecular comparison between the inhibition mode of A/B-typecarboxypeptidases in the zymogen state and by the endogenous inhibitorlatexin."; Garcia-Castellanos R., Bonet-Figueredo R., Pallares I., Ventura S.,Aviles F.X., Vendrell J., Gomis-Rueth F.-X.; Cell. Mol. Life Sci. 62:1996-2014(2005). Cited for: X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 19-421 IN COMPLEX WITH LXNAND ZINC IONS, GLYCOSYLATION AT ASN-260, AND DISULFIDE BOND. | |